Clinical trials: Oligoprogression

NSCLC

Stereotactic Body Radiotherapy for the Treatment of OPD

• Unknown status
• Age: 16 years and older
• Phase 2/3
• Surgery or procedure

HALT is a phase II, randomised multi-centre study with integrated seamless continuation to phase III trial following acceptable safety and feasibility assessment.

Trial name

HALT (NCT03256981)

Testing

SBRT, TKI

Where

29 sites in France, Italy and 3 more

Volunteers

113 people

Sponsor

Institute of Cancer Research, United Kingdom